Home › Funds › Townsend & Associates, Inc › ABBV

Townsend & Associates, Inc position in ABBV

ABBVIE INC · Health Care

Townsend & Associates, Inc reported holding 10,957 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 0.26% of its reported portfolio and ranking #48 among its reported holdings. Townsend & Associates, Inc has disclosed ABBV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)10.96K sh
Reported value held$3.13M
Portfolio Weight0.26%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Townsend & Associates, Inc's ABBV position evolved

Townsend & Associates, Inc first disclosed a stake in ABBV in Q2 2025 at 11,695 shares (US$2.2M). The position peaked in Q3 2026 at 10,957 shares, worth US$3.1M. Across 6 filings, Townsend & Associates, Inc increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,957 shares valued at US$3.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 11.70K $2.23M New
Q3 2025 11.61K $2.67M Reduce
Q4 2025 11.17K $2.42M Reduce
Q1 2026 11.12K $2.23M Hold
Q2 2026 10.96K $2.78M Reduce
Q3 2026 10.96K $3.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Townsend & Associates, Inc held ABBV?

Townsend & Associates, Inc has disclosed ABBV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Townsend & Associates, Inc's current position in ABBV?

As of Q3 2026, Townsend & Associates, Inc holds 10.96K shares of ABBV (ABBVIE INC), valued at $3.13M, representing 0.26% of its reported portfolio and ranking #48.

Has Townsend & Associates, Inc been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Townsend & Associates, Inc held unchanged its position in ABBV. The position peaked in Q3 2026 at 10.96K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.